No definition available.
Other disorders originating in the perinatal period
P16_OTH_DISORD_ORIGINA_PERINA_PERIOD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
366 |
4. Check minimum number of eventsNone |
366 |
5. Include endpoints |
366 |
6. Filter based on genotype QC (FinnGen only) |
366 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P
- Name in latin
- Aliae morbositates origine perinatales
Other disorders originating in the perinatal period
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19070 | 9095 | 9959 |
| Only index persons | 8108 | 4005 | 4103 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.26 | 0.28 |
| Only index persons | 0.15 | 0.15 | 0.16 |
| Median age at first event (years) | |||
| Whole population | 0.08 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.06 | 0.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 366 | 230 | 136 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | 0.60 | 0.92 | 0.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 338
- Matched controls
- 3360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P95
ICD-10 Finland
Fetal death of unspecified cause
+∞
57.9
54
*
P92.5
ICD-10 Finland
Neonatal difficulty in feeding at breast
+∞
52.4
49
*
P94.2
ICD-10 Finland
Congenital hypotonia
341.2
31.3
31
*
P92.9
ICD-10 Finland
Feeding problem of newborn, unspecified
+∞
26.3
25
*
P92.3
ICD-10 Finland
Underfeeding of newborn
+∞
24.2
23
*
P90
ICD-10 Finland
Convulsions of newborn
+∞
22.1
21
*
P92.1
ICD-10 Finland
Regurgitation and rumination in newborn
58.3
19.1
22
*
P92.0
ICD-10 Finland
Vomiting in newborn
73.9
18.9
21
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.4
15.3
47
97
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
9.1
14.8
31
37
P92.2
ICD-10 Finland
Slow feeding of newborn
+∞
13.6
13
*
G02CB01
ATC
bromocriptine; systemic
13.5
13.6
23
18
R4110
NOMESCO Finland
Physiotherapy
2.6
12.8
119
586
O36.4
ICD-10 Finland
Maternal care for intrauterine death
33.3
12.6
16
5
P94.1
ICD-10 Finland
Congenital hypertonia
+∞
12.5
12
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
12.1
54
161
R62.0
ICD-10 Finland
Delayed milestone
3.8
11.7
51
149
P91.02
ICD-10 Finland
Neonatal hypoxic-ischaemic encephalopathy, severe
+∞
11.5
11
*
P21.0
ICD-10 Finland
Severe birth asphyxia
36.2
11.3
14
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.7
10.8
49
148
P85
ICPC
Mental retardation
9.2
10.4
21
24
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
11.7
10.1
18
16
P96.0
ICD-10 Finland
Congenital renal failure
+∞
9.4
9
*
P96.8
ICD-10 Finland
Other specified conditions originating in the perinatal period
+∞
9.4
9
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.9
9.4
60
232
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
24.7
8.9
12
5
P07.3
ICD-10 Finland
Other preterm infants
3.8
8.7
36
101
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
28.2
8.5
11
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
20.5
8.5
12
6
P94.9
ICD-10 Finland
Disorder of muscle tone of newborn, unspecified
+∞
8.3
8
*
A03FA02
ATC
cisapride; oral, rectal
5.0
7.6
23
48
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
13.7
7.4
12
9
RT490
NOMESCO Finland
NA
9.6
7.3
14
15
P91.8
ICD-10 Finland
Other specified disturbances of cerebral status of newborn
+∞
7.3
7
*
WX930
NOMESCO Finland
Thepapeutic hypothermia
+∞
7.3
7
*
P91.9
ICD-10 Finland
Disturbance of cerebral status of newborn, unspecified
+∞
7.3
7
*
Z3226
NOMESCO Finland
Physiotherapist
2.0
7.2
104
603
H50.30
ICD-10 Finland
Intermittent esotropy
5.2
6.9
20
40
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
6.9
83
447
N18.8
ICD-10 Finland
Other chronic renal failure
8.0
6.7
14
18
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
12.5
6.6
11
9
RT190
NOMESCO Finland
NA
10.3
6.6
12
12
RL140
NOMESCO Finland
NA
5.7
6.4
17
31
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.1
6.4
16
27
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
4.9
6.3
19
40
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
18.3
6.3
9
5
P96.9
ICD-10 Finland
Condition originating in the perinatal period, unspecified
+∞
6.3
6
*
P91.1
ICD-10 Finland
Acquired periventricular cysts of newborn
+∞
6.3
6
*
P91.08
ICD-10 Finland
Acute neonatal cerebral ischaemia
+∞
6.3
6
*
P94.8
ICD-10 Finland
Other disorders of muscle tone of newborn
+∞
6.3
6
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.9
6.2
37
138
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
6.1
49
217
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.6
6.1
45
190
RT150
NOMESCO Finland
NA
5.7
6.0
16
29
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
6.0
68
355
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005033) Fetal Nuchal fold Thickness US
37
110
3.63
10.87
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
37
110
3.63
10.87
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
37
115
3.47
10.16
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
38
142
2.87
7.69
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
38
142
2.87
7.69
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
38
142
2.87
7.69
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
142
2.87
7.69
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
150
1009
1.82
7.04
6.1
4.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
145
970
1.82
6.90
6.0
4.8
e6/l
16.3
95.3
0.62
108
743
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
99
588
1.94
6.82
3.9
4.1
e6/l
1.6
2.0
0.30
60
340
(3044640) Blood type and Crossmatch panel - Blood
125
817
1.80
6.32
3.9
3.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
38
160
2.53
6.12
1.7
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
135
916
1.75
5.94
5.7
4.5
e6/l
0.1
0.3
2.07
95
691
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
96
591
1.85
5.83
3.9
3.8
e6/l
0.6
0.6
0.03
56
342
(3018095) Leukocytes [#/volume] in Urine
159
1142
1.69
5.62
7.2
5.6
e6/l
66.4
50.9
0.17
112
766
(36304419) Bacteria [Presence] in Urine
134
920
1.72
5.58
5.5
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
193
1472
1.66
5.33
16.2
13.5
mmol/l
1.2
1.2
0.45
181
1359
(3022670) pH of Venous cord blood
14
35
4.12
5.21
1.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
104
680
1.74
5.09
5.9
10.5
mmol/l
23.8
23.5
0.59
94
662
(3013826) Glucose [Moles/volume] in Serum or Plasma
204
1594
1.63
5.00
7.7
8.5
mmol/l
6.1
6.1
0.01
191
1475
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
41
3.77
4.97
12.3
7.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
891
1.67
4.96
9.4
9.4
g/l
37.3
37.1
0.14
122
856
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
24
4.69
4.81
1.3
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
91
2.75
4.75
3.4
2.1
—
—
—
0
0
(3009343) pH of Capillary blood
109
736
1.68
4.70
13.0
11.4
ph
7.4
7.4
—
6
18
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
109
736
1.68
4.70
13.0
11.4
kpa
5.0
5.0
0.76
104
712
(3018418) pH of Serum or Plasma
92
594
1.73
4.67
7.9
4.0
ph
7.4
7.4
0.32
19
101
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
145
1061
1.61
4.52
9.2
8.9
umol/l
25.3
26.1
0.07
136
982
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
735
1.67
4.49
13.1
11.3
mmol/l
0.7
0.9
0.27
77
541
(3023368) Bacteria identified in Blood by Culture
82
518
1.75
4.48
5.9
4.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
12
7.66
4.38
1.8
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
106
726
1.65
4.28
8.0
11.2
mmol/l
1.3
1.0
0.59
86
557
(3021447) Carbon dioxide [Partial pressure] in Venous blood
106
729
1.64
4.20
8.0
11.1
kpa
5.7
5.7
0.02
101
713
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
27
4.17
4.19
1.3
1.1
—
—
—
0
0
(4211845)
9
13
7.07
4.18
1.8
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
136
2.31
4.15
2.4
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
181
1421
1.54
4.03
16.6
14.6
mmol/l
1.2
1.2
0.42
176
1354
(3028626) Oxygen [Partial pressure] in Capillary blood
100
686
1.63
3.98
13.7
11.1
kpa
9.5
9.7
0.53
95
662
(3026782) Osmolality of Urine
92
618
1.65
3.98
5.0
3.6
mosm/kgh2o
525.1
591.8
1.92
80
537
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
731
1.61
3.93
3.7
3.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
100
690
1.62
3.88
3.7
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
164
1272
1.52
3.79
4.8
3.6
estimate
0.0
0.0
0.00
19
211
(3042936) Bacteria identified in Isolate by Culture
53
309
1.84
3.76
2.4
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
96
661
1.61
3.74
12.8
10.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
165
1285
1.52
3.72
4.9
3.6
estimate
0.0
0.0
0.00
21
221
(3026008) Bacteria identified in Urine by Culture
96
662
1.61
3.72
3.2
2.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
101
708
1.59
3.65
7.9
11.1
kpa
5.2
5.3
0.14
96
693
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
132
2.21
3.56
1.6
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
63
2.78
3.54
1.9
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
93
645
1.59
3.50
5.3
3.7
e6/l
4.2
7.8
1.85
80
568
(3000991) Gas panel - Venous blood
95
667
1.57
3.38
10.9
11.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
145
1116
1.50
3.38
5.4
4.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
222
1861
1.49
3.37
5.7
4.4
—
—
—
0
0
(3015736) pH of Urine
133
1008
1.50
3.33
5.3
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
161
1273
1.47
3.25
7.2
5.3
estimate
0.0
0.0
0.00
21
226
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
39
3.15
3.12
1.8
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
49
298
1.74
3.03
2.5
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
74
503
1.59
3.00
3.0
2.4
u/l
275.7
426.9
0.43
74
486
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
371
1.67
2.99
2.5
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
46
2.89
2.95
1.7
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
55
349
1.68
2.93
3.4
5.0
g/l
0.2
0.2
0.37
55
336
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
52
2.76
2.92
1.3
1.4
u/ml
3.2
4.2
—
5
25
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
302
1.72
2.90
2.5
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
6
8.43
2.75
1.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
8
19
4.28
2.69
1.0
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
296
2692
1.52
2.56
21.5
14.2
mmol/l
139.3
139.4
0.29
290
2626
(3023520) Reticulocytes [#/volume] in Blood
50
321
1.65
2.55
6.3
5.0
e9/l
80.8
63.0
0.84
35
196
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
204
1.79
2.52
2.5
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
136
1082
1.41
2.51
8.3
10.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
198
1679
1.39
2.50
10.3
5.9
u/l
129.8
124.3
0.38
192
1581
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
105
799
1.44
2.47
15.4
16.0
mmol/l
24.4
24.5
0.10
105
799
(3037756) Immunofixation for Serum or Plasma
5
8
6.32
2.38
1.6
2.6
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
8
6.32
2.38
1.4
1.5
mu/l
180.3
90.1
—
5
8
(3023103) Potassium [Moles/volume] in Serum or Plasma
295
2694
1.49
2.37
22.4
14.2
mmol/l
4.0
4.0
0.25
287
2612
(3005719) IgG [Mass/volume] in Serum or Plasma
55
372
1.56
2.28
3.2
3.8
g/l
8.8
8.6
0.22
55
359
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
66
2.33
2.27
1.7
1.5
—
—
—
0
0
(4035726)
32
188
1.77
2.26
1.8
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
20
100
2.06
2.25
5.5
2.1
nmol/l
0.6
0.5
0.57
20
85
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
391
1.54
2.22
3.2
7.8
umol/l
5.3
6.5
0.37
49
323
(3010015) Selenium [Moles/volume] in Serum or Plasma
9
30
3.05
2.16
4.0
2.4
umol/l
0.9
1.1
—
9
30
(3019150) Specific gravity of Urine by Refractometry
80
593
1.45
2.15
5.0
3.1
kg/l
1.0
1.0
0.54
22
113
(4268621)
9
31
2.95
2.08
2.8
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
2.0
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
10
5.05
2.07
3.6
2.5
mmol/l
104.6
106.0
—
5
10
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
290
1.59
2.04
1.8
2.1
iu/l
14.4
14.6
0.02
35
197
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
26
3.12
2.02
1.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
863
1.37
2.00
4.7
3.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
77
2.13
1.99
8.2
9.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
17
84
2.07
1.99
4.6
3.6
ug/l
2.6
6.8
—
9
58
(1616796) Gas panel - Central venous blood
14
64
2.23
1.97
12.6
5.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
11
4.59
1.94
3.6
2.4
mmol/l
4.4
4.0
—
5
11
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
11
4.59
1.94
2.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
33
2.77
1.94
2.6
2.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
65
2.20
1.90
4.2
2.1
u/l
38.3
40.7
0.16
14
60
(3019198) Lymphocytes [#/volume] in Blood
216
1906
1.33
1.88
9.4
9.7
e9/l
2.6
2.4
0.74
184
1642
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
79
2.07
1.88
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
34
2.69
1.87
1.0
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
210
1847
1.32
1.87
9.0
9.6
%
47.0
48.9
1.06
204
1795
(42870588) Differential panel, method unspecified - Blood
167
1423
1.32
1.86
8.7
10.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
17
3.57
1.84
7.2
5.8
ug/l
245.7
214.8
—
6
17
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
244
2196
1.33
1.82
4.0
3.7
pmol/l
14.0
14.4
1.50
231
2030
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
29
2.80
1.80
2.5
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
29
2.80
1.80
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
18
3.37
1.75
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
43
294
1.52
1.72
1.6
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
209
1849
1.30
1.72
9.6
9.7
e9/l
0.0
0.0
0.24
172
1542
(3013336) Amino acids [Identifier] in Serum or Plasma
11
48
2.33
1.72
1.6
2.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
11
48
2.33
1.72
3.6
2.3
umol/l
14.0
13.1
0.21
11
48
(3001604) Monocytes [#/volume] in Blood
209
1850
1.30
1.71
9.6
9.8
e9/l
0.6
0.6
0.24
172
1543
(3022096) Basophils/100 leukocytes in Blood
200
1761
1.30
1.70
9.8
10.0
%
0.6
0.6
0.55
195
1706
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
42
2.42
1.69
2.8
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
150
1.72
1.68
1.9
1.8
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
31
2.62
1.67
8.1
8.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
19
3.19
1.67
2.8
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
19
3.19
1.67
1.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
316
2979
1.44
1.63
12.6
9.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
136
1.74
1.63
1.9
2.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
37
248
1.55
1.63
1.9
2.2
u/l
5.9
6.9
0.28
25
142
(3006504) Eosinophils/100 leukocytes in Blood
203
1798
1.29
1.62
9.7
10.0
%
3.1
3.3
0.38
197
1738
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
14
3.61
1.62
8.8
1.1
u/l
177.1
11.1
—
5
14
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
14
3.61
1.62
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
35
232
1.56
1.62
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
63
2.10
1.61
2.8
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
272
2507
1.33
1.60
4.4
4.1
mu/l
1.9
2.4
0.50
264
2368
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.03
1.58
2.2
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
42
292
1.50
1.57
2.5
2.1
g/l
1.0
1.0
0.03
42
278
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
63
475
1.39
1.54
1.8
2.1
—
—
—
0
0
(4306422)
10
44
2.31
1.54
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
108
1.80
1.54
1.9
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
108
1.80
1.54
1.9
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
101
1.82
1.51
2.3
3.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
13
65
2.04
1.50
2.5
2.0
mmol/l
2.2
2.1
—
8
48
(3012516) Albumin [Mass/volume] in Urine
42
295
1.48
1.50
5.6
3.3
mg/l
70.6
408.2
0.83
34
211
(3007164) IgA [Mass/volume] in Serum or Plasma
144
1231
1.28
1.49
1.9
1.6
g/l
1.6
1.6
0.04
77
623
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
140
1.69
1.49
1.9
2.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
212
1901
1.27
1.48
10.1
10.7
e9/l
0.2
0.2
0.45
179
1618
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
117
1.75
1.48
1.8
1.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
203
1811
1.27
1.48
9.8
10.0
%
8.1
8.3
0.66
198
1758
(3002385) Erythrocyte distribution width [Ratio]
310
2925
1.39
1.48
22.5
16.9
%
13.5
13.3
1.12
305
2888
(40768797) Stomach Pathology biopsy report
35
238
1.52
1.46
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
110
1.77
1.46
11.7
13.0
iu/ml
68.7
423.8
—
6
16
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
73
1.95
1.46
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
59
2.07
1.45
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
79
627
1.33
1.41
5.1
3.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
40
2.28
1.41
10.3
10.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
40
2.28
1.41
2.3
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
74
1.93
1.41
2.0
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
53
2.11
1.40
13.0
8.0
kpa
10.2
9.3
0.73
11
53
(3012501) Base excess in Blood by calculation
11
53
2.11
1.40
13.0
8.0
mmol/l
2.0
2.6
—
5
30
(3013290) Carbon dioxide [Partial pressure] in Blood
11
53
2.11
1.40
13.0
8.0
kpa
5.1
4.9
0.38
11
53
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
317
3010
1.40
1.38
19.0
11.9
mg/l
22.1
21.5
0.15
236
2107
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
23
2.63
1.37
2.2
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
23
2.63
1.37
8.0
8.3
mmol/l
8.7
5.8
—
6
23
(3003396) Base excess in Arterial blood by calculation
29
192
1.55
1.37
10.9
13.9
mmol/l
-0.0
-0.0
0.01
22
158
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
42
2.17
1.34
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
175
1547
1.25
1.33
4.0
3.3
ug/l
51.1
52.6
0.08
170
1469
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
145
1.63
1.32
2.9
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
525
1.34
1.30
2.7
5.2
mg/l
4.2
1.5
0.50
54
385
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
135
0.44
1.30
1.8
1.8
—
—
—
0
0
(3049233) Organic acids panel - Urine
8
34
2.38
1.30
2.0
1.1
—
—
—
0
0
(4034850)
9
44
2.07
1.27
11.2
8.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
44
2.07
1.27
3.0
2.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
35
2.31
1.27
7.3
6.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
35
2.31
1.27
6.9
6.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
119
0.41
1.26
1.6
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
59
457
1.35
1.24
18.7
15.2
mmol/l
6.4
5.2
1.04
59
447
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
45
2.02
1.24
1.0
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
133
1.61
1.20
2.5
2.0
—
—
—
0
0
(3019225) pH of Specimen
18
110
1.67
1.17
5.3
5.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
104
877
1.26
1.17
1.8
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
51
390
1.36
1.17
1.7
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
87
1.76
1.17
1.4
1.3
ug/g
335.5
368.6
—
8
50
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
35
0.00
1.15
0.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
103
1.68
1.15
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
25
168
1.52
1.13
10.8
5.5
%
0.7
0.4
—
9
44
(3021960) Folate [Moles/volume] in Serum or Plasma
48
366
1.36
1.12
1.6
1.3
nmol/l
23.5
20.6
0.67
43
315
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
210
1.47
1.12
1.9
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
104
1.67
1.11
1.9
2.0
—
—
—
0
0
(4027681)
7
32
2.21
1.08
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
68
549
1.29
1.08
1.7
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
180
1624
1.21
1.06
18.7
7.4
ml/min/173m2
102.9
102.0
0.16
136
1135
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
398
1.33
1.04
4.2
2.7
ng/l
18.0
21.7
0.28
28
155
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
2.4
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
74
608
1.27
1.03
1.8
1.6
pmol/l
91.4
99.2
0.81
40
316
(3020682) Albumin/Creatinine [Ratio] in Urine
39
292
1.38
1.03
6.6
3.9
mg/mmol
17.2
66.2
0.43
32
204
(3021440) Promyelocytes/100 leukocytes in Blood
25
172
1.49
1.03
11.6
6.3
%
0.0
0.0
0.49
14
57
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
12
68
1.79
1.01
3.9
4.6
umol/l
25.3
25.1
0.02
12
68
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
35
2.02
1.00
2.6
2.6
umol/l
71.1
57.8
—
7
35
(3013650) Neutrophils [#/volume] in Blood by Automated count
217
2002
1.21
0.99
12.3
11.8
e9/l
3.6
3.5
0.35
181
1672
(40768804) Tissue Pathology biopsy report
87
733
1.25
0.98
1.9
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
116
1.58
0.98
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
116
1.58
0.98
1.5
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
36
1.96
0.97
2.9
2.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
117
1.57
0.95
3.9
4.0
ml/min/173m2
50.3
84.6
—
6
44
(21494434) Karyotype in Bone marrow
7
37
1.91
0.94
1.3
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
70
1.74
0.93
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
52
1.75
0.93
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
321
3092
1.31
0.93
19.4
16.3
%
38.1
38.8
1.23
294
2796
(3007566) Smooth muscle Ab [Titer] in Serum
13
78
1.69
0.92
1.2
1.9
—
52.9
—
0
7
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
200
1839
1.19
0.92
3.0
2.6
mmol/l
5.6
5.4
0.65
188
1689
(3037522) Nuclear Ab [Titer] in Serum
51
406
1.30
0.91
1.4
1.5
titre
746.7
499.7
0.51
12
67
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
353
1.31
0.90
2.5
4.2
ng/l
386.3
1008.2
1.46
23
202
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
174
1584
1.19
0.88
5.0
3.7
mmol/mol
37.3
36.9
0.15
169
1507
(3003694) ABO and Rh group [Type] in Blood
110
961
1.21
0.88
1.9
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
30
2.02
0.87
4.0
2.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
171
1.43
0.85
11.6
6.3
%
0.0
0.0
0.49
11
55
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
31
1.95
0.84
2.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
141
0.56
0.84
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
163
1.44
0.84
1.7
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
206
1.39
0.84
1.8
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
32
241
1.36
0.84
3.6
2.4
u/l
25.5
31.6
0.75
26
200
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
39
303
1.32
0.84
3.9
8.8
ng/l
1052.5
1171.4
0.07
34
260
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
24
172
1.42
0.83
2.8
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
46
1.76
0.83
1.8
4.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
431
1.27
0.82
2.0
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
106
1.53
0.80
2.1
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
6
33
1.83
0.79
1.2
1.1
u/ml
0.1
2.1
—
6
27
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
100
0.49
0.78
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
189
1747
1.17
0.77
12.1
11.8
e9/l
0.1
0.0
0.50
142
1329
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
175
1.40
0.77
2.9
2.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
34
1.78
0.76
3.8
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
34
1.78
0.76
1.3
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
79
678
1.21
0.76
2.2
1.7
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
26
193
1.37
0.75
5.6
4.5
nmol/l
25.6
22.0
0.55
26
188
(3051611) Lipemic interference index of Serum or Plasma
9
54
1.68
0.75
2.0
4.2
—
—
—
0
0
(44790049)
16
108
1.50
0.75
1.7
2.3
—
—
—
0
0
(44790048)
16
108
1.50
0.75
1.7
2.3
—
—
—
0
0
(44806118)
16
108
1.50
0.75
1.7
2.3
—
—
—
0
0
(44790047)
16
108
1.50
0.75
1.7
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
96
841
1.19
0.74
2.6
2.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
185
1.38
0.74
11.6
6.1
%
0.8
0.5
0.77
14
63
(4062490)
9
56
1.62
0.73
1.9
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
347
3399
1.40
0.70
25.0
17.8
e12/l
4.5
4.5
1.04
336
3231
(1002224) Polysomnography panel
9
58
1.57
0.70
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
20
144
1.41
0.69
1.6
1.5
g/l
0.2
0.2
0.09
20
138
(3011288) Drugs identified in Urine by Screen method
27
205
1.34
0.69
5.4
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
170
1.38
0.69
1.0
1.1
u/ml
9.4
7.3
0.19
12
106
(3023511) Choriogonadotropin [Units/volume] in Urine
23
170
1.38
0.69
1.5
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
59
1.54
0.69
10.3
4.2
%
51.9
51.5
—
9
59
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
120
0.58
0.68
1.6
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
19
136
1.42
0.68
14.3
18.0
%
95.9
95.9
0.02
19
136
(3010813) Leukocytes [#/volume] in Blood
347
3401
1.39
0.67
25.1
17.9
e9/l
7.3
7.0
1.45
338
3232
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
242
1.31
0.67
4.0
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
103
1.48
0.66
1.2
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
7
44
1.60
0.65
2.7
4.9
mmol/l
1.7
1.4
—
7
44
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
29
1.73
0.64
1.8
2.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
226
1.31
0.64
1.6
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
147
1.38
0.63
1.6
1.5
g/l
1.1
1.1
0.01
20
139
(3029937) Albumin [Presence] in Urine by Test strip
71
615
1.19
0.63
5.5
3.7
estimate
0.0
0.0
0.00
19
216
(3000494) Fungus identified in Specimen by Culture
35
281
1.27
0.62
1.7
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
35
281
1.27
0.62
2.7
2.4
u/l
10164.9
4434.0
0.38
11
100
(3007461) Platelets [#/volume] in Blood
346
3394
1.36
0.62
25.2
17.9
e9/l
272.5
273.2
0.07
338
3232
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
52
1.55
0.60
2.9
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
141
1.37
0.57
5.9
2.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
159
1.34
0.56
1.0
1.2
u/ml
27.2
8.5
1.00
12
102
(1761868) Lipid panel - Serum or Plasma
70
613
1.18
0.55
2.0
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
61
1.49
0.54
1.6
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
64
1.42
0.52
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
245
0.76
0.50
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
84
1.44
0.50
1.5
1.9
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
385
0.81
0.48
1.3
1.2
iu/ml
116.3
20.6
—
9
108
(4198724)
7
47
1.50
0.48
2.9
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
165
0.72
0.47
1.3
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
18
138
1.32
0.46
14.9
17.7
%
0.7
0.7
0.15
18
138
(3013512) EKG study
39
330
1.20
0.46
3.6
2.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
50
1.41
0.45
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
104
1.36
0.43
2.9
3.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
158
1.28
0.42
5.3
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
19
149
1.29
0.42
1.3
1.3
miu/ml
202.3
276.3
—
9
76
(3032080) INR in Blood by Coagulation assay
69
618
1.14
0.42
4.5
5.1
inr
1.0
1.1
1.24
18
162
(3016038) Potassium [Moles/volume] in Urine
8
57
1.41
0.42
7.5
2.6
mmol/l
23.3
35.8
—
8
57
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
57
1.41
0.42
7.0
3.9
e9/l
3.2
3.5
—
8
57
(40768443) Skin Pathology biopsy report
8
58
1.39
0.42
1.4
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
2.8
—
0
15
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
79
1.40
0.41
1.2
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
138
1292
1.11
0.41
1.9
1.8
u/ml
4.5
4.0
0.11
22
220
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.2
%
86.3
75.4
—
8
60
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
60
1.34
0.40
1.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
4.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
60
671
0.87
0.40
2.6
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
101
0.69
0.40
4.1
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
88
805
1.12
0.39
2.7
3.4
mg/l
3.0
2.6
1.09
83
731
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
35
1.43
0.39
4.0
3.1
—
148.2
—
0
8
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
151
1.27
0.39
1.1
1.1
u/ml
2.5
0.3
—
10
84
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
225
0.79
0.39
1.2
1.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
7.6
—
0
14
(3048689) Calprotectin [Mass/mass] in Stool
67
603
1.14
0.39
2.9
3.4
ug/g
148.6
75.3
1.15
56
482
(3016018) Differential panel - Cerebral spinal fluid
11
80
1.39
0.39
3.0
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
1385
0.90
0.38
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
281
1.19
0.38
3.8
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
116
1.31
0.37
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
116
1.31
0.37
14.4
18.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
134
1.28
0.37
1.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
189
1.23
0.37
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
41
1.47
0.36
12.2
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
387
1.16
0.35
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
87
0.68
0.33
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
88
0.68
0.33
1.5
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
17
137
1.25
0.32
15.1
17.8
%
1.1
1.0
0.12
17
137
(44813793)
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
6
47
1.28
0.32
7.7
7.0
%
1.3
1.4
—
6
41
(3045142) Bone marrow Pathology biopsy report
7
52
1.35
0.31
1.4
1.9
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
52
1.35
0.31
3.7
5.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
16
129
1.25
0.31
1.4
1.5
u/ml
0.4
4.0
—
9
95
(3000492) Spirometry study
24
204
1.19
0.29
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
183
0.81
0.28
1.1
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
63
1.28
0.28
2.3
4.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
62
569
1.11
0.27
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
150
0.79
0.27
1.7
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
74
0.67
0.26
3.8
26.5
%
12.9
11.7
—
5
74
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
9
73
1.24
0.25
1.4
2.9
—
708.3
—
0
8
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
78
1.29
0.24
1.7
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
431
0.89
0.24
1.8
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
22
190
1.17
0.23
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
22
190
1.17
0.23
1.0
1.0
mmol/l
-3.0
-2.1
—
8
47
(1175426) CD3 cells/100 lymphocytes in Blood
13
106
1.23
0.23
2.5
3.6
%
68.5
64.9
0.34
13
106
(3024932) HLA-DR beta [Type]
5
38
1.32
0.23
1.4
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
39
1.29
0.23
1.2
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
146
0.82
0.22
4.5
4.9
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
79
1.27
0.22
4.8
6.1
ug/l
1.6
2.1
—
10
79
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
377
0.89
0.22
1.3
1.2
u/ml
2.5
5.8
—
10
134
(3013931) Oligosaccharides [Presence] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(4146454)
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
1.0
—
0
6
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
12
0.00
0.21
0.0
3.1
—
19.7
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
89
1.24
0.21
2.5
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
48
1.25
0.20
1.0
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
298
1.12
0.20
3.8
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
20.0
—
0
14
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
79.5
—
0
9
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.20
1.0
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
90
1.23
0.19
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
33
299
1.11
0.19
3.9
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
299
1.11
0.19
3.9
1.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
128
1.18
0.18
3.3
4.6
mg/l
319.9
340.8
0.11
15
128
(3020891) Body temperature
7
59
1.19
0.18
6.9
9.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
101
1.19
0.17
4.3
5.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
141
0.85
0.16
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
162
0.86
0.16
1.8
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
217
1.11
0.15
1.4
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
285
1.10
0.14
1.2
1.2
u/ml
0.6
5.7
7.29
19
226
(3024928) Oxygen saturation in Venous blood
13
112
1.17
0.14
2.2
19.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
190
1.11
0.13
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
425
1.07
0.12
2.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
298
1.08
0.12
4.1
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
95
1.16
0.11
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
34
318
1.08
0.11
2.1
1.5
%
1.4
1.4
0.38
34
288
(3044889) 12 lead EKG panel
118
1211
0.96
0.10
3.0
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
115
1.14
0.10
4.1
4.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
212
1.09
0.10
2.5
2.2
u/ml
216.2
177.5
0.31
14
96
(40761536) Microorganisms panel - Urine sediment
21
193
1.09
0.10
8.8
3.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
87
1.15
0.09
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
47
1.06
0.09
3.4
2.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
47
1.06
0.09
3.4
2.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
282
1.07
0.09
1.2
1.3
u/ml
1.2
0.9
0.12
18
214
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
58
1.04
0.08
2.3
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
368
0.95
0.08
2.1
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
64
620
1.04
0.07
11.0
5.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
218
1.06
0.05
2.4
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
22
232
0.94
0.05
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
150
0.93
0.04
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
12
111
1.08
0.04
2.3
4.0
%
16.3
17.9
0.21
12
111
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
250
0.96
0.03
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
299
2978
1.02
0.03
4.2
4.0
—
—
—
0
0
(4010399)
15
158
0.95
0.02
1.7
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
197
1960
1.01
0.02
5.3
4.5
mm/h
8.2
7.9
0.19
190
1848
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
107
0.93
0.02
3.1
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
124
1.05
0.00
1.4
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
27
276
0.98
0.00
1.1
1.2
u/ml
0.6
3.6
2.47
11
100
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
71
716
0.99
0.00
2.7
2.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
98
1.02
0.00
2.6
22.0
%
72.3
72.3
—
10
98
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
10
98
1.02
0.00
1.7
3.6
%
21.5
24.7
—
10
98
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
212
0.99
0.00
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
119
1.01
0.00
4.7
3.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
131
0.99
0.00
1.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
107
1.03
0.00
1.4
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
163
0.98
0.00
1.1
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
13
125
1.04
0.00
1.4
1.6
u/ml
1.1
12.8
—
8
91
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
54
0.92
0.00
1.2
1.5
u/l
36.9
21.3
—
5
45
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
61
0.98
0.00
1.0
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
7
78
0.90
0.00
2.1
2.4
ug/l
9.5
6.9
—
7
69
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
1581.3
—
0
6
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
72.8
—
0
7
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
59
0.85
0.00
3.0
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
59
1.02
0.00
1.2
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
2.0
—
437.4
—
0
5
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
72.4
—
0
7
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
85
0.94
0.00
1.7
2.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
93
0.97
0.00
1.0
1.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
300
1.00
0.00
1.2
1.3
u/ml
1.4
2.6
0.44
20
211
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.5
1.9
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
147.6
—
0
7
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
57
0.88
0.00
1.2
2.3
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.0
—
0.5
—
0
8
(4024509)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
130
1.00
0.00
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.7
—
139.1
—
0
9
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
64
0.94
0.00
3.3
1.8
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
5
50
1.00
0.00
1.4
2.0
u/ml
0.2
16.9
—
5
41
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_DISORD_ORIGINA_PERINA_PERIOD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_OTH_DISORD_ORIGINA_PERINA_PERIOD | 3.808 [2.79, 5.19] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.641 |
During the follow-up period (1.1.1998 — 31.12.2019), 143 out of 8343 females with P16_OTH_DISORD_ORIGINA_PERINA_PERIOD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_OTH_DISORD_ORIGINA_PERINA_PERIOD | 3.23 [2.24, 4.66] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 145 out of 9291 males with P16_OTH_DISORD_ORIGINA_PERINA_PERIOD died.
Mortality risk
Mortality risk for people of age
years, who have P16_OTH_DISORD_ORIGINA_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.346% | 0.536% |
| 5 | 2.175% | 3.4% |
| 10 | 5.482% | 9.188% |
| 15 | 10.433% | 16.711% |
| 20 | 18.473% | 26.947% |
Relationships between endpoints
↥Index endpoint: P16_OTH_DISORD_ORIGINA_PERINA_PERIOD – Other disorders originating in the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data